DEC3-VEN vs. Venetoclax-Based vs. DA Regimens in Newly Diagnosed AML

NCT07712848 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

291

Enrollment

OTHER

Sponsor class

Conditions

AML (Acute Myeloid Leukemia)

Interventions

PROCEDURE: Arm A (VEN+"2+6"DA)
PROCEDURE: Arm B (DEC3-VEN)
PROCEDURE: Arm C ("3+7"DA)

Sponsor

The Second Affiliated Hospital of Kunming Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]